Evaluation of the Effect of Pistacia atlantica Oleoresin on Blood Sugar, Pressure and Lipids in Patients With Type 2 Diabetes: A Single-Blind, Placebo-Controlled Trial
- PMID: 38881209
- PMCID: PMC11180711
- DOI: 10.1002/edm2.504
Evaluation of the Effect of Pistacia atlantica Oleoresin on Blood Sugar, Pressure and Lipids in Patients With Type 2 Diabetes: A Single-Blind, Placebo-Controlled Trial
Abstract
Background: Diabetes mellitus (DM) is a chronic metabolic disorder characterised by high blood sugar (BS) levels due to impaired insulin production or insulin resistance. It is a global health concern with significant implications for morbidity and mortality. Persian medicine has long utilised natural remedies, such as Pistacia atlantica Desf., for various diseases. In this randomised clinical trial, the effects of P. atlantica oleoresin in the improvement of lipid profiles, glucose indices and blood pressure (BP) were assessed in patients with Type 2 DM.
Materials and methods: In this randomised, single-blind, placebo-controlled study, 42 patients with Type 2 DM were randomly allocated to receive either P. atlantica oleoresin or placebo capsule for 3 months. Patients were evaluated prior to and 12 weeks after the beginning of the intervention, in terms of changes in lipid profiles, glucose indices and BP.
Results: After 3 months, the mean BP in patients with DM receiving P. atlantica oleoresin was significantly reduced compared with the baseline (p = 0.001). Also, these changes were significantly higher than those of the control group. The mean of total cholesterol (p = 0.89), low-density lipoprotein (LDL) (p = 0.43) and triglyceride (TG) (p = 0.98) in the intervention group after 3 months was lower than that in the control group, but this difference was not statistically significant.
Conclusion: After 3 months, there was no significant difference between the P. atlantica and control groups in terms of blood sugar and lipid profiles. The mean BP in patients with DM receiving P. atlantica oleoresin was significantly reduced compared with that in the beginning of the study. Also, these changes were significant compared with the control group.
Keywords: Pistacia; Persian medicine; diabetes; integrative medicine; medicinal herbs.
© 2024 The Author(s). Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Antidiabetic, hypolipidemic, and antioxidant activities of Pistacia atlantica: A systematic review and meta-analysis of preclinical studies.Phytother Res. 2023 Sep;37(9):3698-3711. doi: 10.1002/ptr.7898. Epub 2023 Jul 10. Phytother Res. 2023. PMID: 37428094 Review.
-
Efficacy of a standardized herbal product from Pistacia atlantica subsp. Kurdica in type 2 diabetic patients with hyperlipidemia: A triple-blind randomized clinical trial.Complement Ther Clin Pract. 2022 Aug;48:101613. doi: 10.1016/j.ctcp.2022.101613. Epub 2022 Jun 8. Complement Ther Clin Pract. 2022. PMID: 35691258 Clinical Trial.
-
Four Pistacia atlantica subspecies (atlantica, cabulica, kurdica and mutica): A review of their botany, ethnobotany, phytochemistry and pharmacology.J Ethnopharmacol. 2021 Jan 30;265:113329. doi: 10.1016/j.jep.2020.113329. Epub 2020 Sep 1. J Ethnopharmacol. 2021. PMID: 32889035 Review.
-
Pistacia atlantica's effect on ovary damage and oxidative stress in streptozotocin-induced diabetic rats.JBRA Assist Reprod. 2021 Feb 2;25(1):28-33. doi: 10.5935/1518-0557.20200044. JBRA Assist Reprod. 2021. PMID: 32569454 Free PMC article.
-
Effect of Pistacia atlantica kurdica gum on diabetic gastroparesis symptoms: a randomized, triple-blind placebo-controlled clinical trial.Electron Physician. 2018 Jul 25;10(7):6997-7007. doi: 10.19082/6997. eCollection 2018 Jul. Electron Physician. 2018. PMID: 30128090 Free PMC article.
References
-
- Hashemnia M., Nikousefat Z., and Yazdani‐Rostam M., “Antidiabetic Effect of Pistacia atlantica and Amygdalus scoparia in Streptozotocin‐Induced Diabetic Mice,” Comparative Clinical Pathology 24, no. 6 (2015): 1301–1306.
-
- Ahmed Z. B., Yousfi M., Viaene J., et al., “Potentially Antidiabetic and Antihypertensive Compounds Identified From Pistacia atlantica Leaf Extracts by LC Fingerprinting,” Journal of Pharmaceutical and Biomedical Analysis 149 (2018): 547–556. - PubMed
-
- Bagheri S., Sarabi M. M., Khosravi P., et al., “Effects of Pistacia atlantica on Oxidative Stress Markers and Antioxidant Enzymes Expression in Diabetic Rats,” Journal of the American College of Nutrition 38, no. 3 (2019): 267–274. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous